OpenAI is stepping into the legislative arena by supporting several bills designed to mitigate the potential threats posed by advanced artificial intelligence in biotechnology. The company recently endorsed three key bipartisan bills aimed at providing greater security against bio-threats potentially escalated by AI models. The central objective of these bills is to improve access to critical biological data for AI defenses and establish standards for safely developing these tools.
Among the endorsed legislations are the Web of Biological Data Act, the AI-Ready Bio-Data Standards Act, and the SCALE Biology Act. These proposals seek to expand the role of the National Institute of Standards and Technology (NIST) in biosecurity and AI matters. The SCALE Biology Act proposes the establishment of a new NIST program focused on creating measurement standards and ensuring the secure development of biotechnologies. Meanwhile, the AI-Ready Bio-Data Standards Act aims to design a framework that ensures federally funded biodata is accessible and usable for AI research. This initiative supports developing robust evaluation methods for powerful AI models, crucial for maintaining biosecurity standards.
OpenAI’s endorsement reflects its dedication to addressing both the risks AI could pose to biological security and the potential technological defense advancements it could foster. Richard Johnson, OpenAI’s lead on national security risk mitigation, has emphasized the need for vigilance and responsibility. “We need to be concerned about both safety and risk aspects while focusing on empowering defenders with appropriate tools,” Johnson told POLITICO.
Recent studies have highlighted AI’s role in biological engineering, including a noted experiment by Stanford University and the Arc Institute that developed 16 new virus strains using AI technology. Similarly, Anthropic reported several instances where its models were misused by foreign actors in pathogen research, underlining the urgency for stringent regulatory oversight.
The legislative approach by OpenAI aligns with its broader strategy of ensuring AI development is safe, responsible, and transparent. Caitlin Frazer, the Executive Director of the National Security Commission on Emerging Biotechnology, echoed the sentiment that high-quality data must be considered a strategic national resource. This perspective strengthens the foundation for comprehensive AI research and biosecurity protocols.
OpenAI’s previous backing of the Biosecurity Modernization and Innovation Act and the Homestake AI Act shows its ongoing commitment to safe AI integration in biotechnologies. The focus is on establishing a deliberate pace for AI advancement to prevent technological capabilities from surpassing regulation and oversight frameworks.
The company’s proactive stance in cross-sector collaboration seeks to pave the way for a future where artificial intelligence contributes positively to biotechnology while minimizing risks to public safety. As legislative discussions progress, the focus remains on balancing innovation with appropriate safeguards to harness AI’s potential responsibly.
You can read the original article here: [Politico Original Article](https://www.politico.com/news/2026/09/15/openai-backs-bipartisan-push-to-address-ai-biothreats-01077755).
